Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CD8A
REST API REST API
Homo sapiens
CD8A is differentially expressed in 190 experiments: 74 organism parts: thymus, spleen, ... (72 more);, 149 disease states: normal, control, ... (147 more);, 86 cell types 146 cell lines 18 compound treatments and 60 other conditions.
Synonyms CD8
Orthologs ENSGALG00000015900 (Gallus gallus)   A7MAZ7_BOVIN (Bos taurus)   ENSGALG00000013492 (Gallus gallus)   CD8A (Gallus gallus)   ENSGALG00000015852 (Gallus gallus)   Cd8a (Mus musculus)   ENSGALG00000022939 (Gallus gallus)   Cd8a (Rattus norvegicus)   LOC100489117 (Xenopus laevis)   CD8A_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term defense response to virus, plasma membrane, protein binding, extracellular region, transmembrane receptor protein tyrosine kinase signaling pathway, external side of plasma membrane, cell surface receptor linked signaling pathway, protein kinase binding, integral to plasma membrane, immune response, protein homodimerization activity, cell surface, regulation of immune response, coreceptor activity, cytotoxic T cell differentiation, MHC class I protein binding, T cell activation, positive regulation of calcium-mediated signaling, antigen processing and presentation, T cell receptor complex, T cell mediated immunity
InterPro Term Ig_V-set, Ig_sub, Immunoglobulin, Ig-like, Ig_V-set_subgr
UniProt Accession Q6ZVS2, P01732, B4DT80, B8ZZZ4, E7ETP4
Gene-Disease Assocation CD8 DEFICIENCY, FAMILIAL
Search EB-eye ENSG00000153563
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-AFMX-5, E-GEOD-6573, E-MTAB-24, E-MTAB-25, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-1880, E-GEOD-22152, E-MEXP-1006, ... (22 experiments)

Factor Value U/D Experiments
HL-60
3
E-GEOD-24147, E-MTAB-37, E-GEOD-5258
MCF-7
2
E-GEOD-5823, E-GEOD-20081
MOLT4
2
E-MTAB-62, E-MTAB-37
primary cell line
1
E-MTAB-62
sk-n-mc cell line, lentivirus treated
1
E-MTAB-62
sk-n-mc cell line; lentivirus treated
1
E-MTAB-62
140 more value(s).


Cell type

studied in E-TABM-40, E-GEOD-3920, E-GEOD-360, E-GEOD-20677, E-GEOD-13909, ... (38 experiments)

Factor Value U/D Experiments
CD8+ T cell
4
E-AFMX-5, E-GEOD-6740, E-TABM-145, E-GEOD-19069
CD34+
2
E-AFMX-5, E-TABM-145
kidney cell
1
E-MEXP-1216
basophil
1
E-GEOD-3982
bronchial epithelial
1
E-AFMX-5
hematopoietic stem cell
1
E-MEXP-872
80 more value(s).


Disease state

studied in E-GEOD-6872, E-GEOD-2466, E-GEOD-1577, E-GEOD-22148, E-GEOD-9692, ... (46 experiments)

Factor Value U/D Experiments
rheumatoid arthritis
2
E-GEOD-1919, E-GEOD-7307
AIDS-KS, HIV+, nodular (late) stage
2
E-MTAB-62, E-MEXP-66
acute lymphoblastic leukemia
2
E-MTAB-62, E-GEOD-96
control
1
2
E-GEOD-16363, E-GEOD-21912, E-GEOD-8121
juvenile idiopathic arthritis subtype systemic
1
E-GEOD-13501
B-cell lymphoma
1
E-MTAB-62
143 more value(s).


Compound treatment

studied in E-GEOD-1615, E-GEOD-7400, E-GEOD-5258, E-GEOD-3720, E-GEOD-5339, ... (14 experiments)

Factor Value U/D Experiments
phorbol 12-myristate 13-acetate + ionomycin
1
E-GEOD-3720
SDF
1
E-GEOD-7307
17beta-estradiol
4
1
E-GEOD-2292
chloroguine
1
E-GEOD-5418
vanadium pentoxide
1
E-GEOD-5339
bacterial endotoxin
1
1
E-GEOD-3284
12 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

cd1a
studied in E-GEOD-22601

cd34
studied in E-GEOD-22601

cd4
studied in E-GEOD-22601

cd8
studied in E-GEOD-22601

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-2171, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-2191, E-GEOD-19246, E-GEOD-21374, ... (9 experiments)

Clinical treatment
studied in E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-3140, E-MEXP-2359, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-21138, E-GEOD-21887

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, E-TABM-321, ... (8 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-MEXP-1446, E-GEOD-22278

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-5764, E-TABM-740, E-GEOD-2466, ... (34 experiments)

Infection
studied in E-MEXP-561

Injury
studied in E-GEOD-19743

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-21750, E-GEOD-1460

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-GEOD-18791

RNAi
studied in E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743

Sex
studied in E-GEOD-2466, E-GEOD-7307, E-GEOD-16363

Stimulation
studied in E-GEOD-4883, E-GEOD-11886

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-22369, E-GEOD-22368, E-GEOD-19246, E-GEOD-12198

Tumor grading
studied in E-GEOD-4922

Tumor size
studied in E-GEOD-3494

Vehicle
studied in E-GEOD-5258

Processing time: 0.515 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM